Health Care
UK Approves Pfizer/BioNTech Coronavirus Vaccine; Inoculation To Begin Next Week
The United Kingdom became the first country in the world to approve the highly-acclaimed Pfizer/BioNTech Coronavirus vaccine.
Setting the tone for mass inoculation, the new vaccine is reported to be 95 per cent effective in protecting people from COVID-19.
Read More: Top 5 Facts About Pfizer-BioNTech’s 90%-Effective COVID-19 Vaccine
As per the BBC, the MHRA – Britain’s medicine regulator – stated that the vaccine is 95 per cent effective, and that it is safe to be rolled out.
Eight hundred thousand doses are expected to be available in the UK from next week, and people will be contacted by the NHS for inoculation.
Priority will be given to the elderly, caregivers, and NHS staff – though a rounded priority list is expected to be released soon.
Pfizer had stated earlier in November that as much as 50 million vaccines would hit the global markets before the end of this year, while another 1.3 billion will be supplied to health professionals by 2021.
Named the BNT162b2, the mRNA-based vaccine was jointly developed by American pharmaceutical company Pfizer and German biotech company BioNTech.
Sources: BBC, Pfizer
-
Leaders Speak2 months agoDhofar International Development and Investment Company: Driving Sustainable Growth and Strategic Synergies in Oman’s Investment Landscape
-
Economy1 month agoMaal Card: What Oman’s New National Payment Card Means for Everyday Users
-
Events2 months agoOER Corporate Excellence Awards 2025 Honours Entities and Innovations in Oman
-
Arts and Culture2 months agoOminvest and Bait Al Zubair Launch “Future Frames” to Empower Youth through Art and AI
-
News1 month agoSheikh Suhail Bahwan, Chairman of Suhail Bahwan Group, Passes Away
-
Economy1 month agoOman Unveils Official Omani Rial Symbol in Landmark Move to Boost Global Currency Presence
-
News4 weeks agoOIG Appoints New CEO to Lead Its Next Chapter of Excellence
-
News4 weeks agoReport: How India & The Middle East Are Exploiting Immense Economic Synergies
